Where: Building 20, Auditorium
Description
A keynote lecture by Chad Mirkin, Professor and Director of the International Institute for Nanotechnology at Northwestern University.
EVENT DESCRIPTION
Spherical Nucleic Acids (SNAs) are a new class of therapeutic architectures, and this arrangement of DNA or RNA gives rise to unique properties. The emergent properties of SNAs are revolutionizing the way we study, track, and treat disease and in the process, laying the foundation for a new field of rational vaccinology.
We are advancing this vision forward by treating solid tumors with immunostimulatory SNAs that activate an immune response against cancer cells. Additionally, because of their modular and programmable nature, SNAs can be designed to incorporate patient-specific antigens for cancer immunotherapy, highlighting the potential for developing SNAs as personalized medicines. This presentation will describe these advances and illustrate how rational vaccinology may improve human lives.
THE KEYNOTE LECTURE SERIES
The keynote lectures are signature events taking place as part of a series of main lectures aligned with the program’s theme. Since 2010, +150 eminent international guest speakers, Nobel laureates, entrepreneurs, academics and distinguished local and regional leaders and decision-makers have addressed the audience.
Chad Mirkin
Dr. Chad A. Mirkin is the Director of the International Institute for Nanotechnology and the George B. Rathmann Professor of Chemistry, Professor of Chemical and Biological Engineering, Professor of Biomedical Engineering, Professor of Materials Science and Engineering, and Professor of Medicine at Northwestern University. He is a chemist and a world-renowned nanoscience expert, who has authored over 700 papers; he is an inventor on over 1,000 patents and applications worldwide (over 300 issued). Mirkin has been recognized for his accomplishments with over 120 national and international awards. These include the RUSNANOPRIZE, the Dan David Prize, the Wilhelm Exner Medal, the Sackler Prize in Convergence Research, the $500,000 Lemelson-MIT Prize, and the ACS Award for Creative Invention. He was a Member of the President's Council of Advisors on Science and Technology (PCAST, Obama Administration), and one of fewer than 20 scientists, engineers, and medical doctors to be elected to all three US National Academies (National Academy of Medicine, the National Academy of Sciences, and the National Academy of Engineering). He is also a Fellow of the American Academy of Arts and Sciences, the Materials Research Society, the American Chemical Society, the National Academy of Inventors, and the American Institute for Medical and Biological Engineering. He is the Founding Editor of the journal Small, and he has founded multiple companies, including AuraSense, Exicure, TERA-print, and CDJ Technologies. Mirkin holds a B.S. degree from Dickinson College and a Ph.D. degree from Penn State. He was an NSF Postdoc at MIT prior to becoming a Professor at Northwestern in 1991.
No resources found.
No links found.
